Vanguard Group Inc Senti Biosciences, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 707,052 shares of SNTI stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
707,052
Previous 707,052
-0.0%
Holding current value
$1.54 Million
Previous $268,000
26.49%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SNTI
# of Institutions
17Shares Held
8.79MCall Options Held
0Put Options Held
0-
Nea Management Company, LLC Timonium, MD4.43MShares$9.65 Million0.12% of portfolio
-
8 Vc Gp I, LLC Austin, TX2.54MShares$5.53 Million8.67% of portfolio
-
Intel Corp Santa Clara, CA596KShares$1.3 Million0.12% of portfolio
-
Geode Capital Management, LLC Boston, MA246KShares$535,3860.0% of portfolio
-
Two Sigma Investments, LP New York, NY69.8KShares$152,0570.0% of portfolio
About Senti Biosciences, Inc.
- Ticker SNTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,757,100
- Market Cap $95.4M
- Description
- Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...